Emory University
Aprotinin is safe and effective in cardiac surgery
Published in Law and Health Weekly, September 4th, 2004
"Cardiac surgery and cardiopulmonary bypass produces bleeding and the need for allogenic blood product transfusions in many patients. Blood conservation is important in the perioperative management of patients," scientists writing in the journal Orthopedics report.
"Aprotinin, a serine protease inhibitor isolated from bovine lung, is a complex protease inhibitor that is an antifibrinolytic, inhibits contact activation, and decreases the inflammatory response to cardiopulmonary bypass," wrote J.H. Levy and colleagues, Emory University, School of Medicine.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Best Practices, LLC
Drug companies approach brand security issue head on, study shows - Business Update
Altria sees $25 million gain from accounting rule - CytRx Corp.
RNAi company names Benjamin S. Levin general counsel - Drug Enforcement Administration
Government, pain groups release consensus document on prescription drug abuse - Guilford Pharmaceuticals, Inc.
GLIADEL Wafer assigned new DRG designation - Medtronic, Inc.
Medical technology company names senior VP, general counsel, corporate secretary - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
